摘要
目的血液透析后出现高磷血症患者通过醋酸钙与生理钙进行联合透析治疗,对患者的治疗效果进行研究分析。方法2018年7月—2019年7月期间,共随机抽取了60例血液透析后发生高磷血症的患者作为研究目标,通过随机抽签法对60例患者进行随机均分,分成观察组(n=30)和对照组(n=30),将采用碳酸钙和生理钙进行联合透析治疗的患者收纳入对照组,将采用醋酸钙和生理钙进行联合治疗的患者收纳入观察组,对两组患者的治疗总有效率进行比较以及对不良反应的比较情况进行比较。结果观察组患者经过治疗后,得到的临床治疗总有效率得到明显改善,高达96.7%(29/30)。对照组患者的临床治疗总有效率也得到改善,但是低于观察组,只有70.0%(21/30),与对照组相比差异具有统计学意义(P<0.05)。结论通过醋酸钙与生理钙进行联合透析,在血液透析后发生高磷血症的患者,患者的治疗总有效率得到明显提升,治疗效果显著。
Objectiv To study and analyze the treatment effect of patients with hyperphosphatemia after hemodialysis through combined dialysis treatment with calcium acetate and physiological calcium.Methods From July 2018 to July 2019,a total of 60 patients with hyperphosphatemia after hemodialysis were randomly selected as the research target.The 60 patients were randomly divided into observation groups(n=30)and the control group(n=30).Patients who were treated with calcium carbonate and physiological calcium for combined dialysis were included in the control group,and patients who were treated with calcium acetate and physiological calcium for combined treatment were included in the observation group.Compare the total effective rate of treatment of patients and compare the comparison of adverse reactions.Results After treatment,the total effective rate of clinical treatment of the observation group was significantly improved,reaching 96.7%(29/30).The total effective rate of clinical treatment of patients in the control group has also been improved,but it is lower than the observation group,only 70.0%(21/30),which is statistically significant compared with the control group(P<0.05).Conclusion Through combined dialysis with calcium acetate and physiological calcium,patients with hyperphosphatemia after hemodialysis have a significant improvement in the total effective rate of treatment and the treatment effect is significant.
作者
蔡青
CAI Qing(Department of Pharmacy,Wanzhou Distirct Shanghai Hospital,Chongqing 404000,China)
出处
《中国继续医学教育》
2020年第24期143-145,共3页
China Continuing Medical Education
关键词
醋酸钙
生理钙
血液透析
高磷血症
治疗有效率
不良反应
calcium acetate
physiological calcium
hemodialysis
hyperphosphatemia
treatment efficiency
adverse reactions
